Neurokinin Receptor Antagonist Associated to Ondansetron in PONV
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether patients at high risk for postoperative
nausea and vomiting can benefit from aprepitant, ondansetron and dexamethasone in the
perioperative period.
Phase:
Phase 4
Details
Lead Sponsor:
Instituto do Cancer do Estado de São Paulo
Treatments:
Aprepitant Fosaprepitant Neurokinin A Neurokinin-1 Receptor Antagonists Ondansetron